Eloxatin (oxaliplatin)

Approved for Adjuvant treatment of stage III colon cancer after surgical resection, Advanced colorectal cancer in combination regimens (FOLFOX). Forms platinum-DNA adducts primarily through intrastrand cross-links between adjacent guanines or guanine-adenine, inhibiting DNA replication and transcription. Has a different spectrum of activity… Side effects, costs, interactions, manufacturer, and…

Loading full data from Know Your Drugs Institute…